James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 6,000 shares at $67.18 ($406K) on 2019-04-08, disclosed to the SEC on 2019-04-10.
Open-market sale of $406k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.18 | 962 | $65K | 15.9% |
| 2 | $67.18 | 962 | $65K | 15.9% |
| 3 | $67.98 | 2,038 | $139K | 34.1% |
| 4 | $67.98 | 2,038 | $139K | 34.1% |
| Total | $67.72 avg | 6,000 | $406K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |